Home News Ochre Bio enters into multi-year data licence agreement with GSK to further investigate the drivers of liver disease Ochre Bio enters into multi-year data licence agreement with GSK to further investigate the drivers of liver disease 14 June 2024 We are delighted to announce that a Park occupier Ochre Bio has entered a multi-year data licence agreement with GSK to investigate the drivers of liver disease, a condition which can be fatal, killing 1 in 25 people worldwide. The partnership aims to prioritise and speed up the development of new treatments for liver conditions. Ochre Bio enters into a multi-year data licence agreement with GSK to further investigate the drivers of liver disease Read other news articles Get In Touch Share this
